An interventional study of Salbutamol Aerosol and No drugs in Lung Disease,Obstructive, sponsored by snow. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2015-10-30.
Sponsored by snow · Not applicable, Interventional, and Treatment
In the patients with COPD mechanical ventilation, the bronchial dilatation is very common. However, the evaluation of the efficacy of the medical examination and other subjective indicators, such as doctors, depends on the doctor's experience; at present, there is no objective evaluation index. For patients with mechanical ventilation, the risk of cross infection can not only increase the risk of cross infection, but also increase the workload of clinical doctors and nurses. Therefore, this study proposes an objective evaluation method to evaluate the response of COPD patients to bronchial dilation. The hypothesis of this study can be used to guide the clinical medication through the test of the bronchus. If the patients with bronchial dilation test positive were used in the test, the patients were not used. In this evaluation method, the changes of airway resistance were measured by the accurate measurement of the patients with inhaled bronchial dilatation.
2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.
This study's planned enrollment of 120 is above the median of 66 across 1,837 interventional studies indexed under Lung Diseases, Obstructive.
Browse Lung Diseases, Obstructive studies →This is the only study on the registry with snow as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
First of all, investigators need to give patients to do the test, the result is more than 12% is positive group, less than 12% is negative group.Second, randomly selected into the atomization group
Drug: Salbutamol Aerosol
First of all, investigators need to give patients to do the test, the result is more than 12% is positive group, less than 12% is negative group.Secondly, the random selection is not the atomization group
Drug: No drugs
Also known as: Ammonium bromide bromide aerosol
airway resistance
The first test of bronchial dilatation
Time frame: 1 day
Respiratory mechanics index:PEEPi
Time frame: 1 day
Mechanical ventilation time
Time frame: 28 days
length of hospital stay
Time frame: 30 days
Costs of hospitalization expenses
Time frame: 30 days
Routine blood test:Eosinophilic cells
Time frame: 7days
This study is status unknown, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.